IBB
iShares Biotechnology ETF
stockNASDAQETF
The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 210.71 | 2026-09-28 | -2.59% | -0.455 |
| 1M | 211.92 | 2026-09-04 | -3.14% | 0.996 |
| 3M | 195.31 | 2026-07-06 | +5.09% | 0.626 |
| 6M | 168.83 | 2026-04-06 | +21.58% | 0.633 |
| 1Y | 150.52 | 2025-10-06 | +36.37% | 0.769 |
| 2Y | 143.90 | 2024-10-04 | +42.64% | — |
| 5Y | 155.79 | 2021-10-05 | +31.75% | 0.847 |
iShares Biotechnology ETF (NASDAQ:IBB) stock price today is $205.26, and today's volume is 2,090,367. IBB is down 0.340% today. The 30 day average volume is 1.54M. IBB market cap is $10.48B with 51.05M shares outstanding.